CD163 and cutaneous melanoma: CD209, CD163, CSF1, and MMD were related to M2 macrophage proportions in cutaneous melanoma, breast carcinoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, prostate cancer, renal cancer, and lung adenocarcinoma (Figures 7A–D).